Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Broutet N, Jeronimo j, Kumar S, Almonte M, Murillo R, Huy NVQ, Denny L, kapambwe S, et al. Preventive Medicine, 2022; 155 (106906). doi.org/10.1016/j.ypmed.2021.106906.
Management of advanced squamous cell carcinoma of the vulva. Rogers LJ. Cancers, 2022; 14(167). doi.org/10.3390/cancers14010167.
Clinical utility of reflex testing with cancer biomarkers to improve diagnostic accuracy of primary human papillomavirus screening. Johnson LG, Saidu R, Svanholm-Barrie C, Boa R, Moodley J, Tergas A, Persing D, Campbell SA, Tsai WY, Wright TC, Denny L, Kuhn L. Cancer Epidemiol Biomarkers Prev, 2022; Jan 13. Doi:10.1158/1055-9965.EPI-21-0972.
Identification of the human papillomavirus genotypes, according to the Human Immunodeficiency Virus status in a cohort of women from Maputo, Mozambique. Maueia C, Murahwa A, Manjate A, Andersson S, Sacarlal J, Kenga D, Mussa T, Williamson A-L. Viruses, 2022; 14 (24). https://doi.org/10.3390/v14010024
Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design. Machalek D, Rees H, Chikandiwa A, Munthali R, Travill D, Mbulawa Z, Petoumenos K, Delany-Moretlwe S, Kaldor J, HOPE Study Team. BMJ Open 2022; 12:e059968. doi:10.1136/bmjopen-2021-059968.
Cervical cancer is a disease of inequity: here's how to save 60 million lives. Denny L. The Conversation. 2022, Feb 2.
High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention. Mbulawa ZZA, Phohlo K, Garcia-Jardon M, Williamson A-L, Businge CB. PLOS One 2022; 9 March. https://doi.org/10.1371/journal.pone.0264498.
Building opportunities to improve quality of life for women with ovarian cancer in low- and middle-income countries: the Every Woman study. Noll F, Adams T, Cohen R, Soerjomataram I, Reid F. International Journal of Gynaecological Cancer 2022; March: 1-2. doi.10.1136/ijgc-2022-003449.
Cancer in sub-Saharan Africa: A Lancet Oncology Commission. Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, Ali Z, Anderson BO, Anorlu R, Avery S, Barango P, Bih N, Booth CM, Brawley OW, Dangou J-M, Denny L, Dent J, Elmore SNC, Elzawawy A, Gashumba D, Geel J, Graef K, Gupta S, Gueye S-M, Hammad N, Hessissen L, Ilbawi AM, Kambugu J, Kozlakidis Z, Manga S, Maree L, Mohammed SI, Msadabwe S, Mutebi M, Nakaganda A, Ndlovu N, Ndoh K, Ndumbalo J, Ngoma M, Ngoma T, Ntizimira C, Rebbeck TR, Renner L, Romanoff A, Rubagumya F, Sayed S, Sud S, Simonds H, Sullivan R, Swanson W, Vanderpuye V, Wiafe B, Kerr D. The Lancet 2022; epub 9 May. Doi.org/10.1016/S1470-2045(21)00720-8.
Transkingdom analysis of the female reproductive tract reveals bacteriophages form communities. Madere FS, Sohn M, Winbush AK, Barr B, Grier A, Palumbo C, Java J, Meiring T, Williamson A-L, Bekker LG, Adler DH, Monaco CL. Viruses 2022; 14.
A case report of a patient with a primary ovarian carcinoid tumour who has right heart failure. Mohlaba GM, Adams T, Wu HT, Mbatani N. South Afr J Gynaecol Oncol 2022; 14(1): 6-9. https://doi.org/10.36303/SAJGO.2022.14.1.353
Molecular identification of cervical microbes in HIV-negative and HIV-positive women in an African setting using a customized bacterial vaginosis microbial DNA quantitative PCR (qPCR) array. Taku O, Onywera H, Mbulawa ZZA, Businge CB, Meiring TL, Williamson A-L. Microbiology Spectrum 2022, epub. 1 June 2022. https://doi.org/10.1128/spectrum.02229-21
Cervical cancer therapies: current challenges and future perspectives. Burmeister CA, Khan SF, Schafer G, Mbatani N, Adams T, Moodley J, Prince S. Tumour Virus Research 2022; 13: June 2022. https://doi.org/10.1016/j.tvr.2022.200238
Adenocarcinoma of mammary-like glands of the vulva: a case report and literature review. Kalwiba C, Lunn J, Wu HT, Rogers L. South African Journal of Gynaecological Oncology. 2022; 14(1): 1-3. https://doi.org/10.36303/SAJGO.2022.14.1.369.
Microbiological and behavioral determinants of genital HPV infections among adolescent girls and young women warrant the need for targeted policy interventions to reduce HPV risk. Onywera H, Mabunda SA, Williamson A-L, Mbulawa ZZA. Frontiers in Reproductive Health. 2022; doi:10.3389/frph.2022.887736.
Assessment of the implementation context in preparation for a clinical study of machine-learning algorithms to automate the classification of digital cervical images for cervical cancer screening in resource-constrained settings. Castor D, Saidu R, Boa R, Mbatani N, Mutsvangwa TEM, Moodley J, Denny L, Kuhn L. Frontiers in Health Services. 2022; doi:10.3389/frhs.2022.1000150.
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022. Prudden HJ, Achilles SL, Schocken C, Broutet n, Canfell K, Akaba H, Basu P, Bhatla N, Chirenje ZM, Delany-Moretlwe S, Denny L, et al. Vaccine, 2022; 40(41): 5843-5855. doi.org/10.1016/j.vaccine.2022.08.020.
The experience of providing cervical cancer care in a very low-resourced health care setting: Eastern Cape, South Africa. Giyose N. HPV World. www.HPVWorld.com,207
Xpert HPV: Basis and key results in best trials. Denny L, Saidu R, Kuhn L. HPV World. www.HPVWorld.com,64
Clinical manifestations of HPV-associated disease: a South African perspective. Adams TA, Denny L. HPV World. www.HPVWorld.com,200
Cancer service delivery and the impact of the COVID-19 pandemic in sub-Saharan Africa: a scoping review. Ezenwankwo EF, Nnaji CA, Moodley J. eCancer 2022; 16: 1485. https://doi.org/10.3332/ecancer.2022.1485.
A mass spectrometry-based approach for the identification of KpnB1 binding partners in cancer cells. Okpara MO, Hermann C, van der Watt PJ, Garnett S, Blackburn JM, Leaner VD. Scientific Reports, 2022; 12: 20171. https://doi.org/10.1038/s41598-022-24194-6.
Defining opportunities to improve survival and quality of life for women with ovarian cancer in 24 low- and middle-income countries: The Every Woman Study. Reid F, Adams T, Bajwa A, Charlton P, Cohen R, Eiken M, Mackay C, Mustapha A, Shaffi A, Ling WY. Cancer Control 2022; 44-51. (Published in association with the International Network for Cancer Treatment and Research).
The impact of positive margins and crypt involvement in excisional procedures of the cervix on recurrence rates of premalignant disease of the cervix. Addae H, Mhembere M, Adams T. South Afrcan Journal of Gynaecological Oncology 2022; 14(1): 16-21. https://doi.org/10.36303/SAJGO.2022.14.1.370
Editorial
HPV Vaccine introduction and implementation in LMICs. Denny L. Vaccine, 2022. doi.org/10.1016/j.vaccine.2022.02.074
Improving surgical and medical outcomes, beyond maternal mortality. Paterson A, Cairncross L, Adams T, Biccard BM. S Afr J Obstet Gynaecol 2022;27(1):2-3. https://doi.org/10.7196/SAJOG.2022.v27i1.2048
Same-day test and treat for early detection and treatment of cervical cancer in LMICs. Saidu R. Lancet 2022; https://doi.org/10.1016/S2214-109X(22)00316-3